<?xml version="1.0" encoding="utf-8"?>
<article article-type="other" dtd-version="1.1" xml:lang="en"
    xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
    <front>
        <journal-meta>
            <journal-id journal-id-type="publisher-id">APA6</journal-id>
            <journal-id journal-id-type="nlm-ta">Brain Behav</journal-id>
            <journal-title-group>
                <journal-title>Brain and Behavior</journal-title>
                <abbrev-journal-title abbrev-type="pubmed">Brain Behav.</abbrev-journal-title>
            </journal-title-group>
            <issn pub-type="epub">2162-3279</issn>
            <publisher>
                <publisher-name>John Wiley and Sons</publisher-name>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.5555/BRB3-2019-12-0787</article-id>
            <article-id pub-id-type="publisher-id">BRB3-2019-12-0787</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Original Research</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Blood <bold>pressure</bold> after follow up in a stroke prevention
                    clinic</article-title>
                <alt-title alt-title-type="right-running">Blood pressure after stroke</alt-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <contrib-id authenticated="true" contrib-id-type="orcid">
                        https://orcid.org/0000-0003-2217-5904</contrib-id>
                    <name>
                        <surname>Hornnes</surname>
                        <given-names>Agnete Hviid</given-names>
                    </name>
                    <degrees>RN</degrees>
                    <degrees>MPH</degrees>
                    <degrees>PhD</degrees>
                    <xref ref-type="aff" rid="BRB3-2019-12-0787-aff1" />
                </contrib>
                <contrib contrib-type="author">
                    <name>
                        <surname>Poulsen</surname>
                        <given-names>Mai Bang</given-names>
                    </name>
                    <degrees>MD</degrees>
                    <degrees>PhD</degrees>
                    <xref ref-type="fn" rid="BRB3-2019-12-0787-afn-0001">*</xref>
                    <xref ref-type="aff" rid="BRB3-2019-12-0787-aff1" />
                </contrib>
                <aff id="BRB3-2019-12-0787-aff1">
                    <institution content-type="dept">Department of
                        Neurology</institution>, <institution>Herlev og Gentofte
                        Hospital</institution> , <addr-line>Borgmester Ib Juuls Vej 1</addr-line> , <addr-line>
                        <postal-code>2730</postal-code>
                        <city>Herlev</city>
                    </addr-line>, <country>Denmark</country></aff>
            </contrib-group>
            <author-notes>
                <corresp id="BRB3-2019-12-0787-cor1">Corresponding author: Agnete Hviid Hornnes <email
                        xlink:href="agnete.hviid.hornnes@regionh.dk">agnete.hviid.hornnes@regionh.dk</email>
                    FAX: 0045 3868 4031</corresp>
                <fn id="BRB3-2019-12-0787-afn-0001">
                    <label>*</label>
                    <p>Mai Bang Poulsen, MD, PhD Department of
                        Neurology Nordsjællands Hospital Dyrehavevej
                        29 3400 Hillerød Denmark</p>
                </fn>
                <fn id="BRB3-2019-12-0787-afn-0002">
                    <p>ClinicalTrials.gov NCT03782857.</p>
                </fn>
                <fn fn-type="con">
                    <p content-type="fn-title">Contributor Information</p>
                    <p>Agnete Hviid Hornnes, Email: agnete.hviid.hornnes@regionh.dk <ext-link
                            ext-link-type="uri" xlink:href="https://orcid.org/0000-0003-2217-5904">
                        https//orcid.org/0000-0003-2217-5904</ext-link> Mai Bang Poulsen, Email:
                        mai.bang.poulsen.02@regionh.dk</p>
                    <p>Both authors have made substantial contributions to conception and design and
                        acquisitions and analyses             <?AuthorQuery id="Q3" queryText="Check meaning - US English uses different spellings for the noun &quot;analyses&quot; (more than one analysis) and the verb form &quot;analyzes&quot;"?> and interpretation of data and have; and been
                        involved in writing the manuscript and given final approval of the version
                        to be published. Both authors have participated sufficiently in the work to
                        take public responsibility for the content; and agree to be accountable for
                        all aspects of the work in ensuring that questions related to the accuracy
                        or integrity of any part of the work are appropriately investigated and
                        resolved.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="ppub">
                <year />
            </pub-date>
            <volume />
            <supplementary-material id="S1"
                mime-subtype="vnd.openxmlformats-officedocument.wordprocessingml.document"
                mimetype="application" xlink:href="attachment:7d9d686b-5488-44a5-a1c5-46351e7f9312">
                <caption>
                    <title>final manuscript-hum-huili-dbh-suicide-20200707_figures (9)
                    </title>
                </caption>
            </supplementary-material>
            <history>
                <date date-type="received">
                    <day>09</day>
                    <month>12</month>
                    <year>2019</year>
                </date>
                <date date-type="rev-recd">
                    <day />
                    <month />
                    <year />
                </date>
                <date date-type="accepted">
                    <day>27</day>
                    <month>04</month>
                    <year>2020</year>
                </date>
            </history>
            <permissions />
            <abstract>
                <sec>
                    <title>Objectives</title>
                    <p>In Denmark 25% of hospital admissions with stroke are recurrent strokes. With
                        thrombolytic treatment more patients survive with only minor disability.
                        This promising development should be followed up by intensive secondary
                        prevention. Hypertension is the most important target. We aimed at testing
                        the hypotheses that early follow up in a preventive clinic would result in
                        1) A higher proportion of patients with blood pressure at target, 2) Time to
                        stroke recurrence, myocardial infarction and death would be longer in the
                        intervention group compared to controls.</p>
                </sec>
                <sec>
                    <title>Materials and Methods</title>
                    <p>Eligible patients admitted to the stroke unit of Herlev Hospital were
                        randomized shortly before discharge to intervention or control group. Of 78
                        included participants data from 73 was available for follow up nine months
                        after inclusion. Patients in the intervention group were seen in the clinic
                        within one week. In case of hypertension treatment was initiated or supplied
                        with a new drug. We used individual targets for blood pressure according to
                        diagnosis of stroke and patients’ comorbidity. Patients in the
                        intervention group had a median of five visits to the preventive clinic.</p>
                </sec>
                <sec>
                    <title>Results</title>
                    <p>In the intervention group blood pressure was treated to target in 25 patients
                        (69%) versus 14 (38%) in the control group ( <italic>p</italic> = 0.007).
                        Median time to first event was 44 months (4–49) in the intervention group
                        and 19 months (4–37) in controls ( <italic>p</italic> = 0.316).</p>
                </sec>
                <sec>
                    <title>Conclusions</title>
                    <p>Treatment of hypertension to individual targets after stroke is feasible. It
                        may postpone recurrent stroke and death in stroke survivors.</p>
                </sec>
            </abstract>
            <kwd-group kwd-group-type="author">
                <title>KEYWORDS </title>
                <kwd>secondary prevention</kwd>
                <kwd>stroke recurrence</kwd>
                <kwd>blood pressure</kwd>
                <kwd>blood pressure target</kwd>
                <kwd>randomized controlled trial</kwd>
            </kwd-group>
            <funding-group>
                <award-group>
                    <funding-source>National Institutes of Health</funding-source>
                    <principal-award-recipient>Berkeley</principal-award-recipient>
                    <award-id>GM18458</award-id>
                </award-group>
                <award-group>
                    <funding-source>National Science Foundation</funding-source>
                    <award-id>DMS-0204674</award-id>
                    <award-id>DMS-0244638</award-id>
                </award-group>
            </funding-group>
            <counts>
                <count count="0" count-type="box" />
                <fig-count count="3" />
                <table-count count="2" />
                <equation-count count="0" />
                <ref-count count="25" />
                <word-count count="4484" />
            </counts>
        </article-meta>
    </front>
    <body>
        <sec id="BRB3-2019-12-0787-sec1" sec-type="intro">
            <label>1</label>
            <title>INTRODUCTION</title>
            <p>Over the last two decades continuous development of thrombolytic treatment of acute
                ischemic stroke (IS) has improved safety and functional outcome in treated patients <xref
                    ref-type="bibr" rid="BRB3-2019-12-0787-bib-0001 BRB3-2019-12-0787-bib-0002">
                    <sup>1;2</sup>
                </xref>thus increasing the possibility of survival
                with no or only minor disability. With this fact and the ongoing aging of
                populations in mind <xref ref-type="bibr" rid="BRB3-2019-12-0787-bib-0003">
                    <sup>3</sup>
                </xref>the secondary prevention after stroke seems
                more important than ever. In 1998 the Copenhagen Stroke Study reported a recurrence
                rate of 23%. <xref ref-type="bibr" rid="BRB3-2019-12-0787-bib-0004">
                    <sup>4</sup>
                </xref>According to the Danish Stroke Registry our
                national recurrence rate was 25% in 2011. <xref ref-type="bibr"
                    rid="BRB3-2019-12-0787-bib-0005">
                    <sup>5</sup>
                </xref>
            </p>
            <p>Hypertension is an important risk factor for stroke recurrence. <xref ref-type="bibr"
                    rid="BRB3-2019-12-0787-bib-0004 BRB3-2019-12-0787-bib-0006 BRB3-2019-12-0787-bib-0007 BRB3-2019-12-0787-bib-0008">
                    <sup>4;6–8</sup>
                </xref>Lowering blood pressure (BP) after stroke
                or transitory ischemic attack (TIA) by 10/5 mm Hg has been associated with reduced
                risk of stroke recurrence by 24% and myocardial infarction (MI) by 21%. <xref
                    ref-type="bibr" rid="BRB3-2019-12-0787-bib-0009">
                    <sup>9</sup>
                </xref>
            </p>
            <p>Observational studies have demonstrated the difficulties in lowering BP after stroke
                with rates of BP treated to target ranging from 28% to 73% <xref ref-type="bibr"
                    rid="BRB3-2019-12-0787-bib-0010 BRB3-2019-12-0787-bib-0011 BRB3-2019-12-0787-bib-0012 BRB3-2019-12-0787-bib-0013">
                    <sup>10–13</sup>
                </xref>and interventions aimed at control of BP
                after stroke have not yet found a successful model. <xref ref-type="bibr"
                    rid="BRB3-2019-12-0787-bib-0014 BRB3-2019-12-0787-bib-0015 BRB3-2019-12-0787-bib-0016 BRB3-2019-12-0787-bib-0017 BRB3-2019-12-0787-bib-0018 BRB3-2019-12-0787-bib-0019">
                    <sup>14–19</sup>
                </xref>Fahey and coworkers have reviewed the
                literature aimed at improving control of BP in hypertensive subjects. One large
                study using an organized system of regular visits to a clinic was efficient in
                producing a large decrease in BP and reduction of all-cause mortality compared to
                referral to usual primary care. This was achieved by using a stepwise escalation of
                treatment until target was reached. <xref ref-type="bibr"
                    rid="BRB3-2019-12-0787-bib-0020">
                    <sup>20</sup>
                </xref>Other methods had variable or no effect,
                only nurse or pharmacist led care seemed promising.</p>
            <sec>
                <title>Aims and hypotheses</title>
                <p>The aim of the present study was to test the hypotheses that follow up after
                    stroke in a specialized nurse led physician supervised clinic with stepwise
                    escalation of BP- and lipid lowering treatment would result in</p>
                <sec>
                    <title>Primary endpoint</title>
                    <sec>
                        <title>A greater proportion of participants with BP at target</title>
                        <p>Secondary endpoints: <list id="L1" list-type="simple">
                                <list-item>
                                    <p>A greater reduction of BP</p>
                                </list-item>
                                <list-item>
                                    <p>A greater proportion of participants with LDL-cholesterol
                            treated to target</p>
                                </list-item>
                                <list-item>
                                    <p>A greater reduction of LDL-cholesterol</p>
                                </list-item>
                                <list-item>
                                    <p>Longer time to recurrence of stroke, MI and death</p>
                                </list-item>
                                <list-item>
                                    <p>in the intervention group compared to controls</p>
                                </list-item>
                            </list>
                        </p>
                    </sec>
                </sec>
                <sec>
                    <title>BoxedText test</title>
                    <boxed-text>
                        <label>BoxedTextLabel</label>
                        <caption>
                            <title>BoxedTextCaptionTitle</title>
                        </caption>
                        <sec>
                            <title>Key messages</title>
                            <list list-type="bullet">
                                <list-item>
                                    <p>The benefits of geriatric day hospital care have been
                                        controversial for many years.</p>
                                </list-item>
                                <list-item>
                                    <p>This systematic review of 12 randomised trials comparing
                                        a variety of day hospitals with a range of alternative
                                        services found no overall advantage for day hospital care.</p>
                                </list-item>
                                <list-item>
                                    <p>Day hospitals had a possible advantage over no comprehensive
                                        care in terms of death or poor outcome, disability, and use
                                        of
                                        resources.</p>
                                </list-item>
                                <list-item>
                                    <p>The costs of day hospital care may be partly offset by
                                        a reduced use of hospital beds and institutional care among
                                        survivors.</p>
                                </list-item>
                            </list>
                        </sec>
                    </boxed-text>
                </sec>
            </sec>
        </sec>
        <sec id="BRB3-2019-12-0787-sec2" sec-type="methods">
            <label>2</label>
            <title>MATERIELS AND METHODS</title>
            <p>Before the initiation of the study the authors attended a three-day course in
                treatment of hypertension arranged by the Danish Society of Hypertension. The
                recommendations of our national guidelines regarding BP targets were in line with
                those given by the American Stroke Association in force at the time of initiation of
                the study: “An absolute target BP level and reduction are uncertain and should be
                individualized.” <xref ref-type="bibr" rid="BRB3-2019-12-0787-bib-0021">
                    <sup>21</sup>
                </xref>Following the advice given by the Danish
                Society of Hypertension we used the following targets: A BP &lt; 140/90 mm Hg was
                considered at target in non-diabetic patients. In patients aged 80 years or more a
                BP of 150/90 mm Hg was acceptable if further treatment was not tolerated. In case of
                severe carotid stenosis or a history of ischemic heart disease BP should not be
                lower than 130/80 mm Hg. In patients with diabetes or hemorrhagic stroke we aimed at
                a BP &lt; 130/80 mm Hg. Untreated patients without hypertension were categorized as
                normotensive, untreated hypertensive patients as having unknown hypertension,
                treated patients without hypertension as treated to target, and treated patients
                with hypertension as having untreated hypertension.</p>
            <p>LDL-cholesterol should be &lt; 2.5 mmol/l in patients with IS or TIA in
                non-diabetic patients and in case of diabetes &lt; 2.0 mmol/l.</p>
            <p>A sample size calculation showed that 24 patients in each group were needed to show a
                difference of 10 mm Hg in the development of systolic BP (80% power).</p>
            <sec id="BRB3-2019-12-0787-sec2.1">
                <label>2.1</label>
                <title>Study sample and setting</title>
                <p>From June 2012 to February 2013 all patients diagnosed with a stroke or TIA at
                    the stroke unit of Herlev Gentofte Hospital, University of Copenhagen were
                    considered for inclusion in the study. Patients should be without cognitive
                    deficits that would prevent their active participation and they should be
                    discharged to their own home. The last author used computer-generated block
                    randomization procedures with stratification by hypertension (1:1). The
                    allocation sequence was concealed, and we aimed at equal numbers in the two
                    groups. Shortly before discharge the first author approached eligible patients
                    for oral and written information about the study. Where written informed consent
                    to participation was achieved BP was measured before a concealed envelope
                    administered by a secretary was opened revealing the allocation to either
                    intervention or control group.</p>
                <p>The research protocol was approved by the ethics committee of the Capital Region
                    of Denmark (H-3-2011–152) and by the Danish Data Protection Agency
                    (2012–41-0429). The study was conducted according to all common ethical
                    standards including the rules given by the Declaration of Helsinki. Patients
                    randomized to the control group had the usual treatment: one visit in the
                    outpatient clinic of the stroke unit three months after discharge. Patients
                    randomized to the intervention group had an appointment with the first author
                    within one week after discharge. The first author undertook all visits in the
                    preventive clinic.</p>
            </sec>
            <sec id="BRB3-2019-12-0787-sec2.2">
                <label>2.2</label>
                <title>Procedures and intervention</title>
                <p>BP was measured at every visit after at least five minutes rest in a sitting
                    position in an arm chair. BP was measured simultaneously in both arms followed
                    by two measurements with 10-min intervals using the arm with the highest
                    systolic BP. In case of hypertension the first author would suggest initiation
                    or intensification of antihypertensive treatment. The last author would accept
                    or suggest an alternative and do the prescription. Patients would come to the
                    clinic for control of BP and relevant blood tests every 3–4 weeks until
                    BP was at target. After five weeks on lipid lowering drugs treatment was
                    intensified if needed. Patients who did not tolerate lipid lowering medication
                    were referred to a dietitian. In motivated patients home BP measurements were
                    performed using patients’ own monitor or by lending patients a BP monitor
                    between visits.</p>
                <p>Patients in the intervention group had a mean of five visits to the clinic with
                    addition of new drugs rather than adding more of the same drug in case of
                    hypertension. Although we used minimum doses to prevent adverse effects, many
                    patients had unacceptable side effects necessitating change to another class of
                    antihypertensive drug.</p>
                <p>Patients were informed about the importance of life-long adherence with all
                    preventive medication. Those with elevated BP or receiving antihypertensive
                    treatment were advised in salt reduction, smokers were advised to stop smoking
                    and all patients were informed about the benefits of 30 min of moderate physical
                    activity daily. Likewise, information about the risk of an intake of alcohol
                    above seven drinks per week in women and 14 drinks in men was part of the
                    program as well as the benefits of weight reduction in overweight patients with
                    hypertension or diabetes.</p>
            </sec>
            <sec id="BRB3-2019-12-0787-sec2.3">
                <label>2.3</label>
                <title>Follow up</title>
                <p>Participants in both groups were invited to the usual follow up visit three
                    months after discharge at the outpatient clinic of the stroke unit as well as a
                    follow up visit in the study a median of 9 (IQR 8–11) months after
                    inclusion.</p>
                <p>In accordance with the protocol the final follow up visits were performed by
                    nurses in the outpatient clinic with measurement of BP and blood-cholesterols.
                    Patients were asked not to reveal their group allocation but blinding of the
                    nurses was not possible. Patients were interviewed about adherence to all
                    preventive medications as well as their present life style. For practical
                    purposes a minority of visits were performed by the first author. To do
                    intention to treat analyses           <?AuthorQuery id="Q1" queryText="Check meaning - US English uses different spellings for the noun &quot;analyses&quot; (more than one analysis) and the verb form &quot;analyzes&quot;"?> we used last observation carried forward regarding
                    the endpoints of the study where patients had died or did not respond to the
                    invitation to a follow up visit. Thus, we used the last recorded values in five
                    patients in the intervention group and in seven controls.</p>
                <p>After a median of 65 months (IQR: 61–66) from inclusion data on vascular
                    events and death were attained from the hospital based medical records covering
                    all hospitals of the region.</p>
            </sec>
            <sec id="BRB3-2019-12-0787-sec2.4">
                <label>2.4</label>
                <title>Statistics</title>
                <p>Data were entered into Excel and imported into SAS. Statistical analyses           <?AuthorQuery id="Q2" queryText="Check meaning - US English uses different spellings for the noun &quot;analyses&quot; (more than one analysis) and the verb form &quot;analyzes&quot;"?> were
                    performed by the first author according to a pre-established statistical
                    analysis plan. We used Chi square test (for the primary outcome) or Fisher’s
                    exact test as appropriate for comparison of proportions, and for change from
                    baseline we used McNemar’s test. For continuous variables we used t-test or
                    Mann-Whitney’s test*. Change from baseline was analyzed by the paired t-test or
                    Wilcoxon signed rank sum test* (*where data were not normally distributed). We
                    used SAS 9.4 for Windows and <italic>p</italic> &lt; 0.05 was considered
                    significant.</p>
            </sec>
        </sec>
        <sec id="BRB3-2019-12-0787-sec3" sec-type="results">
            <label>3</label>
            <title>RESULTS</title>
            <p>We included 78 patients in the study. Due to revision of stroke diagnoses in four
                participants and as one participant never turned up for the intervention, data on 73
                participants were available for follow up ( <xref ref-type="fig"
                    rid="BRB3-2019-12-0787-fig-0001">Figure 1</xref> ). The median stay in hospital
                was 4 days (IQR: 3–6). As seen from <xref ref-type="table"
                    rid="BRB3-2019-12-0787-tbl-0001">Table 1</xref> most participants had no or
                slight disability.</p>
            <fig fig-type="figure" id="BRB3-2019-12-0787-fig-0001" position="float">
                <label>FIGURE 1</label>
                <caption>
                    <p>Flow chart of participants</p>
                </caption>
                <graphic xlink:href="BRB3-2019-12-0787-fig-0001.png" />
            </fig>
            <table-wrap id="BRB3-2019-12-0787-tbl-0001" position="float">
                <label>TABLE 1</label>
                <caption>
                    <title>Baseline characteristics of 73 patients</title>
                </caption>
                <table frame="hsides" rules="groups">
                    <col width="52.14%" />
                    <col width="11.92%" />
                    <col width="14.9%" />
                    <col width="13.1%" />
                    <col width="7.94%" />
                    <thead>
                        <tr>
                            <th align="left" scope="col"
                                style="border-top: solid 0.50pt; border-bottom: solid 0.50pt"
                                valign="top">Characteristics</th>
                            <th align="left" scope="col"
                                style="border-top: solid 0.50pt; border-bottom: solid 0.50pt"
                                valign="top">All <break /> ( <italic>n</italic> = 73)</th>
                            <th align="left" scope="col"
                                style="border-top: solid 0.50pt; border-bottom: solid 0.50pt"
                                valign="top">Intervention ( <italic>n</italic> = 36)</th>
                            <th align="left" scope="col"
                                style="border-top: solid 0.50pt; border-bottom: solid 0.50pt"
                                valign="top">Control ( <italic>n</italic> = 37)</th>
                            <th align="left" scope="col"
                                style="border-top: solid 0.50pt; border-bottom: solid 0.50pt"
                                valign="top">P</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" scope="row" style="border-top: solid 0.50pt"
                                valign="middle">Sex, female</td>
                            <td align="left" style="border-top: solid 0.50pt" valign="middle">29
                                (40)</td>
                            <td align="left" style="border-top: solid 0.50pt" valign="middle">15
                                (42)</td>
                            <td align="left" style="border-top: solid 0.50pt" valign="middle">14
                                (38)</td>
                            <td align="left" style="border-top: solid 0.50pt" valign="middle">0.74</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="middle">Age (years),
                                mean ± SD</td>
                            <td align="left" valign="middle">66 ± 12</td>
                            <td align="left" valign="middle">63 ± 13</td>
                            <td align="left" valign="middle">68 ± 11</td>
                            <td align="left" valign="middle">0.08</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Length of education <break />
                                &lt; 10 years <break /> 10 – 12 years <break /> &gt; 12 years</td>
                            <td align="left" valign="top">12 (17) <break /> 22 (30) <break /> 38
                                (53)</td>
                            <td align="left" valign="top">6 (17) <break /> 10 (29) <break /> 19 (54)</td>
                            <td align="left" valign="top">6 (16) <break /> 12 (33) <break /> 19 (51)</td>
                            <td align="left" valign="top">0.95</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Diagnosis of stroke <break />
                                Ischemic Stroke <break /> TIA <break /> Hemorrhagic stroke</td>
                            <td align="left" valign="top">63 (87) <break /> 9 (12) <break /> 1 (1)</td>
                            <td align="left" valign="top">33 (92) <break /> 3 (8)</td>
                            <td align="left" valign="top">30 (81) <break /> 6 (16) <break /> 1 (3)</td>
                            <td align="left" valign="top">0.60 <sup>a</sup></td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Recurrent stroke</td>
                            <td align="left" valign="top">11 (15)</td>
                            <td align="left" valign="top">5 (14)</td>
                            <td align="left" valign="top">6 (16)</td>
                            <td align="left" valign="top">1.00 <sup>a</sup></td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Modified Rankin Scale score
                                &gt; 2</td>
                            <td align="left" valign="top">5 (6)</td>
                            <td align="left" valign="top">1 (3)</td>
                            <td align="left" valign="top">4 (11)</td>
                            <td align="left" valign="top">0.36 <sup>a</sup></td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Antihypertensive medication
                                before stroke</td>
                            <td align="left" valign="top">39 (53)</td>
                            <td align="left" valign="top">15 (42)</td>
                            <td align="left" valign="top">24 (65)</td>
                            <td align="left" valign="top">0.047</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Antihypertensive medication at
                                discharge</td>
                            <td align="left" valign="top">46 (63)</td>
                            <td align="left" valign="top">20 (56)</td>
                            <td align="left" valign="top">26 (70)</td>
                            <td align="left" valign="top">0.19</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Cholesterol lowering
                                medication before stroke</td>
                            <td align="left" valign="top">25 (34)</td>
                            <td align="left" valign="top">11 (31)</td>
                            <td align="left" valign="top">14 (38)</td>
                            <td align="left" valign="top">0.51</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Cholesterol lowering
                                medication at discharge</td>
                            <td align="left" valign="top">65 (89)</td>
                            <td align="left" valign="top">35 (97)</td>
                            <td align="left" valign="top">30 (81)</td>
                            <td align="left" valign="top">0.03</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Diabetes at baseline</td>
                            <td align="left" valign="top">14 (19)</td>
                            <td align="left" valign="top">5 (14)</td>
                            <td align="left" valign="top">9 (24)</td>
                            <td align="left" valign="top">0.37 <sup>a</sup></td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Diabetes at discharge</td>
                            <td align="left" valign="top">16 (22)</td>
                            <td align="left" valign="top">6 (17)</td>
                            <td align="left" valign="top">10 (27)</td>
                            <td align="left" valign="top">0.29</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Atrial fibrillation at
                                baseline</td>
                            <td align="left" valign="top">7 (10)</td>
                            <td align="left" valign="top">3 (8)</td>
                            <td align="left" valign="top">4 (11)</td>
                            <td align="left" valign="top">1.00 <sup>a</sup></td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Atrial fibrillation at
                                discharge</td>
                            <td align="left" valign="top">12 (16)</td>
                            <td align="left" valign="top">6 (16)</td>
                            <td align="left" valign="top">6 (17)</td>
                            <td align="left" valign="top">1.00</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Unhealthy dieting <sup>b</sup></td>
                            <td align="left" valign="top">59 (82)</td>
                            <td align="left" valign="top">25 (71)</td>
                            <td align="left" valign="top">34 (92)</td>
                            <td align="left" valign="top">0.03</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Current smoking</td>
                            <td align="left" valign="top">19 (26)</td>
                            <td align="left" valign="top">11 (31)</td>
                            <td align="left" valign="top">8 (22)</td>
                            <td align="left" valign="top">0.62</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Alcohol above limits <sup>c</sup></td>
                            <td align="left" valign="top">23 (32)</td>
                            <td align="left" valign="top">12 (34)</td>
                            <td align="left" valign="top">11 (30)</td>
                            <td align="left" valign="top">0.68</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">Sedentary lifestyle <sup>d</sup></td>
                            <td align="left" valign="top">17 (24)</td>
                            <td align="left" valign="top">9 (26)</td>
                            <td align="left" valign="top">8 (22)</td>
                            <td align="left" valign="top">0.68</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" valign="top">BMI ≥ 25</td>
                            <td align="left" valign="top">46 (63)</td>
                            <td align="left" valign="top">24 (67)</td>
                            <td align="left" valign="top">22 (59)</td>
                            <td align="left" valign="top">0.52</td>
                        </tr>
                        <tr>
                            <td align="left" scope="row" style="border-bottom: solid 0.50pt"
                                valign="top">Self-rated health: fair, poor, or very poor</td>
                            <td align="left" style="border-bottom: solid 0.50pt" valign="top">34
                                (47)</td>
                            <td align="left" style="border-bottom: solid 0.50pt" valign="top">15
                                (43)</td>
                            <td align="left" style="border-bottom: solid 0.50pt" valign="top">19
                                (51)</td>
                            <td align="left" style="border-bottom: solid 0.50pt" valign="top">0.47</td>
                        </tr>
                    </tbody>
                </table>
                <table-wrap-foot>
                    <p>Values are expressed as frequencies (%) or as
                        mean ± standard deviations</p>
                    <fn id="BRB3-2019-12-0787-tfn1">
                        <label>
                            <sup>a</sup>
                        </label>
                        <p>Fisher’s exact test. <sup>b</sup> Less than 600 g of fruit and vegetables
                            per day, fish for dinner less than twice per week. <sup>c</sup> More
                            than 7 drinks per week in women/more than 14 drinks per week in men. <sup>
                            d</sup> Less than 30 min of moderate physical activity per day.</p>
                    </fn>
                </table-wrap-foot>
            </table-wrap>
            <p>Less than 20% of patients had a baseline BP treated to target ( <xref ref-type="fig"
                    rid="BRB3-2019-12-0787-fig-0002">Figure 2</xref> ). Twenty-eight patients (78%)
                in the intervention group and 29 patients (78%) in the control group had a 3-month
                visit in the outpatient clinic. Here 15 patients (42%) in the intervention group had
                their BP and blood cholesterol measured and so had 23 patients (62%) in the control
                group. At follow up patients in both groups reported a median of two visits
                including BP measurement at the general practitioner´s office since discharge from
                hospital.</p>
            <fig fig-type="figure" id="BRB3-2019-12-0787-fig-0002" position="float">
                <label>FIGURE 2</label>
                <caption>
                    <p>Blood pressure and treatment of hypertension at baseline in 73 patients
                        (%)</p>
                </caption>
                <graphic xlink:href="BRB3-2019-12-0787-fig-0002.png" />
            </fig>
            <sec id="BRB3-2019-12-0787-sec3.1">
                <label>3.1</label>
                <title>Primary endpoint</title>
                <p>Follow up visits showed that 25 patients (69%) in the intervention group had a BP
                    at target versus 14 (38%) of controls ( <italic>p</italic> = 0.007). In four
                    patients (10%) in the intervention group antihypertensive medication remained
                    unchanged since discharge versus 23 (62%) of controls ( <italic>p</italic> &lt;
                    0.0001) illustrated by the differences in BP treated to target as well as
                    untreated hypertension in <xref ref-type="fig" rid="BRB3-2019-12-0787-fig-0003">Figure
                    3</xref> .</p>
                <fig fig-type="figure" id="BRB3-2019-12-0787-fig-0003" position="float">
                    <label>FIGURE 3</label>
                    <caption>
                        <p>Blood pressure and treatment of hypertension at follow up in 73 patients
                            (%)</p>
                    </caption>
                    <graphic xlink:href="BRB3-2019-12-0787-fig-0003.png" />
                </fig>
            </sec>
            <sec id="BRB3-2019-12-0787-sec3.2">
                <label>3.2</label>
                <title>Secondary endpoints</title>
                <p>Median reduction in systolic BP was 11 mm Hg (-5-19) with 14 mm Hg (IQR: 5–21) in
                    the intervention group and 3 mm Hg (IQR -11-17) in the control group ( <italic>p</italic>
                    = 0.045). Median reduction in diastolic BP was 2 mm Hg (-2-11) with 7 mm Hg (IQR
                    -1-13) in the intervention group and 1 mm Hg (IQR -6-8) in the control group ( <italic>
                    p</italic> = 0.04).</p>
                <p>There was no difference between the groups regarding LDL-cholesterol treated to
                    target with 32 patients (89%) at target in the intervention group versus 29
                    patients (78%) in the control group ( <italic>p</italic> = 0.21). We found
                    significant reductions in LDL-cholesterol in both groups, but no difference
                    between the groups: 1.6 (IQR: 0.4–2.2) mmol/l in the intervention group versus
                    0.8 (IQR: 0.4–1.8) mmol/l among controls ( <italic>p</italic> = 0.18).</p>
                <p>In 11 patients (31%) in the intervention group cholesterol lowering medication
                    remained unchanged since discharge versus 29 (78%) of controls ( <italic>p</italic>
                    &lt; 0.0001).</p>
                <p>The combined endpoint of both BP and LDL-cholesterol at target was achieved in 22
                    (61%) of patients in the intervention group and in 10 patients (27%) in the
                    control group ( <italic>p</italic> = 0.003). At the end of the study 24 patients
                    (68%) in the intervention group measured their BP at home versus 14 (38%) of
                    controls ( <italic>p</italic> = 0.03).</p>
                <p>The only significant change in lifestyle was a reduction in current smokers by
                    four in the control group ( <xref ref-type="table"
                        rid="BRB3-2019-12-0787-tbl-0002">Table 2</xref> ).</p>
                <table-wrap id="BRB3-2019-12-0787-tbl-0002" position="float">
                    <label>TABLE 2</label>
                    <caption>
                        <title>Nine months follow up of 73 patients</title>
                    </caption>
                    <table frame="hsides" rules="groups">
                        <col width="52.91%" />
                        <col width="11.06%" />
                        <col width="14.16%" />
                        <col width="11.5%" />
                        <col width="10.37%" />
                        <thead>
                            <tr>
                                <th align="left" scope="col"
                                    style="border-top: solid 0.50pt; border-bottom: solid 0.50pt"
                                    valign="top">Characteristics</th>
                                <th align="left" scope="col"
                                    style="border-top: solid 0.50pt; border-bottom: solid 0.50pt"
                                    valign="top">All <break /> ( <italic>n</italic> = 73)</th>
                                <th align="left" scope="col"
                                    style="border-top: solid 0.50pt; border-bottom: solid 0.50pt"
                                    valign="top">Intervention <break /> ( <italic>n</italic> = 36)</th>
                                <th align="left" scope="col"
                                    style="border-top: solid 0.50pt; border-bottom: solid 0.50pt"
                                    valign="top">Control <break /> ( <italic>n</italic> = 37)</th>
                                <th align="left" scope="col"
                                    style="border-top: solid 0.50pt; border-bottom: solid 0.50pt"
                                    valign="top">P</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" scope="row" style="border-top: solid 0.50pt"
                                    valign="top">Systolic BP, mm Hg, mean ± SD</td>
                                <td align="left" style="border-top: solid 0.50pt" valign="top">134
                                    ± 21</td>
                                <td align="left" style="border-top: solid 0.50pt" valign="top">130
                                    ± 17</td>
                                <td align="left" style="border-top: solid 0.50pt" valign="top">137
                                    ± 24</td>
                                <td align="left" style="border-top: solid 0.50pt" valign="top">0.12</td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" valign="top">Diastolic BP, mm Hg, mean
                                    ± SD</td>
                                <td align="left" valign="top">78 ± 11</td>
                                <td align="left" valign="top">78 ± 10</td>
                                <td align="left" valign="top">78 ± 12.8)</td>
                                <td align="left" valign="top">0.94</td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" valign="top">Antihypertensive
                                    medication</td>
                                <td align="left" valign="top">55 (75)</td>
                                <td align="left" valign="top">29 (81)</td>
                                <td align="left" valign="top">26 (70)</td>
                                <td align="left" valign="top">0.31</td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" valign="top">100% compliance with AHM ( <italic>
                                    n</italic> = 45)</td>
                                <td align="left" valign="top">38 (84)</td>
                                <td align="left" valign="top">23 (89)</td>
                                <td align="left" valign="top">15 (79)</td>
                                <td align="left" valign="top">0.38</td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" valign="top">LDL-cholesterol, mmol/l ( <italic>
                                    n</italic> = 72), mean ± SD</td>
                                <td align="left" valign="top">1.9 ± 0.8</td>
                                <td align="left" valign="top">1.9 ± 0.7</td>
                                <td align="left" valign="top">2.0 ± 0.8</td>
                                <td align="left" valign="top">0.66</td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" valign="top">Cholesterol lowering
                                    medication</td>
                                <td align="left" valign="top">64 (88)</td>
                                <td align="left" valign="top">32 (89)</td>
                                <td align="left" valign="top">32 (86)</td>
                                <td align="left" valign="top">0.76</td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" valign="top">100% compliance with CLM ( <italic>
                                    n</italic> = 52)</td>
                                <td align="left" valign="top">46 (89)</td>
                                <td align="left" valign="top">24 (86)</td>
                                <td align="left" valign="top">22 (92)</td>
                                <td align="left" valign="top">0.50</td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" valign="top">Unhealthy dieting <sup>b</sup></td>
                                <td align="left" valign="top">59 (81)</td>
                                <td align="left" valign="top">26 (72)</td>
                                <td align="left" valign="top">33 (89)</td>
                                <td align="left" valign="top">0.76</td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" valign="top">Current smoker</td>
                                <td align="left" valign="top">15 (21)</td>
                                <td align="left" valign="top">11 (31)</td>
                                <td align="left" valign="top">4 (11)</td>
                                <td align="left" valign="top">0.046 <sup>a</sup></td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" valign="top">Alcohol &gt; limits <sup>c</sup></td>
                                <td align="left" valign="top">20 (27)</td>
                                <td align="left" valign="top">11 (31)</td>
                                <td align="left" valign="top">9 (24)</td>
                                <td align="left" valign="top">0.55</td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" valign="top">Sedentary lifestyle <sup>d</sup></td>
                                <td align="left" valign="top">16 (22)</td>
                                <td align="left" valign="top">7 (20)</td>
                                <td align="left" valign="top">9 (24)</td>
                                <td align="left" valign="top">0.66</td>
                            </tr>
                            <tr>
                                <td align="left" scope="row" style="border-bottom: solid 0.50pt"
                                    valign="top">BMI ≥ 25</td>
                                <td align="left" style="border-bottom: solid 0.50pt" valign="top">43
                                    (59)</td>
                                <td align="left" style="border-bottom: solid 0.50pt" valign="top">21
                                    (58)</td>
                                <td align="left" style="border-bottom: solid 0.50pt" valign="top">22
                                    (60)</td>
                                <td align="left" style="border-bottom: solid 0.50pt" valign="top">
                                    0.92</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <p>Values are expressed as frequencies (%) or as
                            mean ± standard deviations. Abbreviations:
                            AHM, antihypertensive medication; CLM, cholesterol lowering
                            medication.</p>
                        <fn id="BRB3-2019-12-0787-tfn2">
                            <label>
                                <sup>a</sup>
                            </label>
                            <p>Fisher’s exact test. <sup>b</sup> Less than 600 g of fruit and
                                vegetables per day, fish for dinner less than twice per week. <sup>c</sup>
                                More than 7 drinks per week in women/more than 14 drinks per week in
                                men. <sup>d</sup> Less than 30 min of moderate physical activity per
                                day.</p>
                        </fn>
                        <p />
                    </table-wrap-foot>
                </table-wrap>
                <p>Regarding vascular complications and death, we found 32 events in 22 patients
                    after a median of 65 months. Median time to first event was 26 months (IQR:
                    4–49) with a median of 44 months (IQR: 11–49) in the intervention group and 19
                    months (IQR: 4–37) in the control group ( <italic>p</italic> = 0.32). All in
                    all, we found 11 events in nine patients in the intervention group: two
                    recurrent strokes, three cases of TIA, and six patients died versus 21 events in
                    13 patients in the control group: seven recurrent strokes, five cases of TIA,
                    one MI, and seven patients died ( <italic>p</italic> = 0.49).</p>
            </sec>
        </sec>
        <sec id="BRB3-2019-12-0787-sec4" sec-type="discussion">
            <label>4</label>
            <title>DISCUSSION</title>
            <p>In this randomized clinical trial, a larger proportion of patients in the
                intervention group compared to controls had BP within the above-mentioned limits and
                the study fulfilled the aim of the primary endpoint.</p>
            <p>A systematic review of interventions aimed at modifiable risk factor control for
                secondary prevention of stroke revealed improvement in achieving BP target. <xref
                    ref-type="bibr" rid="BRB3-2019-12-0787-bib-0022">
                    <sup>22</sup>
                </xref>However, as opposed to our study the review
                showed no significant change in systolic og diastolic BP.</p>
            <p>In a study of integrated care with five prearranged visits to patients’ general
                practitioner versus usual care systolic BP at target set to 140 mm Hg was found in
                75% versus 58% at 12-month follow up. <xref ref-type="bibr"
                    rid="BRB3-2019-12-0787-bib-0019">
                    <sup>19</sup>
                </xref>We set individual targets for BP according
                to patients’ type of stroke, comorbidities and age. This is well in line with
                recommendations given by European Society of Hypertension, <xref ref-type="bibr"
                    rid="BRB3-2019-12-0787-bib-0023">
                    <sup>23</sup>
                </xref>but as stated by Boan et al., not quite in
                accordance with international stroke guidelines. <xref ref-type="bibr"
                    rid="BRB3-2019-12-0787-bib-0024">
                    <sup>24</sup>
                </xref>
            </p>
            <p>In a study where patients with minor stroke were randomized to six clinic visits by a
                pharmacist (intervention) or by a nurse (active control) aiming at treating both BP
                and LDL-cholesterol to target, 43% of patients in the pharmacist-led clinic met
                those two targets and so did 31% in the nurse-led clinic. <xref ref-type="bibr"
                    rid="BRB3-2019-12-0787-bib-0025">
                    <sup>25</sup>
                </xref>In our study this combined endpoint was met
                in 22 (61%) of patients in the intervention group. Regarding BP in control 80% of
                patients in the pharmacist led clinic had systolic BP in control after six months
                versus 90% in the nurse led clinic. This is a far greater proportion than the 69% in
                our study. However, almost two thirds of patients had a baseline BP within the
                limits. The opposite was the case in our study with two thirds presenting with
                elevated BP. Both studies show that a dedicated follow up with stepwise escalation
                of preventive medication may be the way to reach the targets of the two important
                risk factors for recurrent stroke. In both studies five-six visits were needed,
                which is far beyond our usual treatment. However, despite visits to the outpatient
                clinic as well as to the general practitioner the proportion of patients with
                unchanged medication since discharge in the control group illustrate the necessity
                of frequent visits to a dedicated preventive facility. Considering the preventive
                effect of BP lowering, and - though insignificant - the difference in time to first
                event as well as the smaller proportion of events in the intervention group as found
                in our study, it may be well worth the time and resources for patients, their
                relatives and society.</p>
            <sec id="BRB3-2019-12-0787-sec4.1">
                <label>4.1</label>
                <title>Strengths and limitations</title>
                <p>Our study has some limitations. Most participants had a minor stroke and patients
                    had to be independent and without severe cognitive deficits, which is not
                    representative of a general stroke population. With only 73 participants caution
                    is called for in the drawing of conclusions from the results. Nonetheless, we
                    decided to reorganize the outpatient clinic of our stroke unit as of October
                    2014 implementing strategies of the present study.</p>
                <p>The strength of the study is the individual target for BP taking into account the
                    diagnosis of stroke as well as important comorbidity as recommended by Boan et
                    al. <xref ref-type="bibr" rid="BRB3-2019-12-0787-bib-0024">
                        <sup>24</sup>
                    </xref>Five-year follow up on vascular
                    complications and death is another important advantage.</p>
            </sec>
        </sec>
        <sec id="BRB3-2019-12-0787-sec5" sec-type="conclusions">
            <label>5</label>
            <title>CONCLUSIONS</title>
            <p>In conclusion, the feasibility study has demonstrated that timely follow up of stroke
                patients in a dedicated preventive outpatient clinic may result in BP and
                cholesterol treated to target in most patients. To some extent it may postpone time
                to stroke recurrence, MI and death.</p>
        </sec>
    </body>
    <back>
        <ack>
            <title>ACKNOWLEDGMENTS</title>
            <p>None. <xref ref-type="bibr" rid="BRB3-2019-12-0787-bib-0021">
                    <sup>21</sup>
                </xref>
            </p>
        </ack>
        <fn-group>
            <fn fn-type="conflict">
                <p content-type="fn-title">CONFLICT OF INTEREST</p>
                <p>None.</p>
            </fn>
        </fn-group>
        <sec sec-type="data-availability">
            <title>DATA AVAILABILITY</title>
            <p>The data that support the findings of this study are not available due to national
                privacy or ethical restrictions.</p>
        </sec>
        <ref-list>
            <title>Reference List</title>
            <ref id="BRB3-2019-12-0787-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Wahlgren</surname>, <given-names>N.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Ahmed</surname> , <given-names>N.</given-names></string-name>, <string-name>
                            <surname>Eriksson</surname> , <given-names>N.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Aichner</surname> , <given-names>F.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Bluhmki</surname> , <given-names>E.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Dávalos</surname> , <given-names>A.</given-names></string-name>
                    , 
            <etal>. . .</etal>
            <string-name>
                            <surname>Vanhooren</surname> , <given-names>G.</given-names></string-name>,
                    &amp; the <collab>Safe
                            Implementation of Thrombolysis in Stroke-MOnitoring STudy
                            Investigators</collab></person-group>. ( <year>2008</year> ). <article-title>Multivariable
                    analysis of outcome predictors and adjustment
                        of main outcome results to baseline data profile in randomized controlled
                    trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy
                    (SITS-MOST).</article-title>
          <source>Stroke</source> , <volume>39</volume> , <fpage>
                    3316</fpage> – <lpage>3322</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1161/STROKEAHA.107.510768</pub-id>
          <pub-id pub-id-type="pmid">
                    18927461</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Wahlgren</surname>, <given-names>N.</given-names></string-name>
                    </person-group>
                    (
          <year>2009</year> ). <article-title>Systemic thrombolysis in
                    clinical
                        practice: What have we learned after the Safe Implementation of Thrombolysis
                    in Stroke Monitoring Study?</article-title>
          <source>Cerebrovascular Diseases
                    (Basel, Switzerland)</source> , <volume>27</volume> ( <supplement>Suppl 1</supplement>
                    ), <fpage>168</fpage> – <lpage>176</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1159/000200456</pub-id>
          <pub-id pub-id-type="pmid">19342848</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Thorvaldsen</surname>, <given-names>P.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Davidsen</surname> , <given-names>M.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Brønnum-Hansen</surname> , <given-names>H.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>Schroll</surname> , <given-names>M.</given-names></string-name>
                    </person-group>
                    (
          <year>1999</year> ). <article-title>Stable stroke occurrence despite
                    incidence reduction in an aging population: Stroke trends in the danish
                    monitoring trends and determinants in cardiovascular disease (MONICA)
                        population.</article-title>
          <source>Stroke</source> , <volume>30</volume> , <fpage>
                    2529</fpage> – <lpage>2534</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1161/01.STR.30.12.2529</pub-id>
          <pub-id pub-id-type="pmid">
                    10582973</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0004">
                <label>4</label>
                <?AuthorQuery id="Q4" queryText="eXtyles has not updated the authors because of a name mismatch. Please compare &quot;J&#x00F8;rgensen&quot; with &quot;Jerrgensen&quot;. The CrossRef authors are Jerrgensen, H. S., Nakayama, H., Reith, J., Raaschou, H. O., &amp; Olsen, T. S.. (Ref. 4 &quot;J&#x00F8;rgensen, Nakayama, Reith, Raaschou, Olsen, 1997&quot;)"?>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Jørgensen</surname>, <given-names>H.
                                S.</given-names></string-name>, <string-name>
                            <surname>Nakayama</surname> , <given-names>H.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Reith</surname> , <given-names>J.</given-names></string-name>, <string-name>
                            <surname>Raaschou</surname> , <given-names>H.
                                O.</given-names></string-name>, &amp; <string-name>
                            <surname>Olsen</surname> , <given-names>T.
                                S.</given-names></string-name>
                    </person-group>( <year>
                    1997</year> ). <article-title>Stroke recurrence: Predictors, severity, and
                    prognosis. The
                        Copenhagen Stroke Study.</article-title>
          <source>Neurology</source> , <volume>
                    48</volume> , <fpage>891</fpage> – <lpage>895</lpage> . <pub-id
                        pub-id-type="doi">https://doi.org/10.1212/WNL.48.4.891</pub-id>
          <pub-id
                        pub-id-type="pmid">9109873</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="other">Danish Stroke Registry. Danish Stroke
                    Registry, annual report 2011. 2011. Ref Type: Generic.</mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Friday</surname>, <given-names>G.</given-names></string-name>, <string-name>
                            <surname>Alter</surname> , <given-names>M.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>Lai</surname> , <given-names>S.
                                M.</given-names></string-name>
                    </person-group>( <year>
                    2002</year> ). <article-title>Control of hypertension and risk of stroke
                    recurrence.</article-title>
          <source>Stroke</source> , <volume>33</volume> , <fpage>
                    2652</fpage> – <lpage>2657</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1161/01.STR.0000033929.62136.6F</pub-id>
          <pub-id
                        pub-id-type="pmid">12411656</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Lai</surname>, <given-names>S.
                                M.</given-names></string-name>, <string-name>
                            <surname>Alter</surname> , <given-names>M.</given-names></string-name>, <string-name>
                            <surname>Friday</surname> , <given-names>G.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>Sobel</surname> , <given-names>E.</given-names></string-name>
                    </person-group>
                    (
          <year>1994</year> ). <article-title>A multifactorial analysis of
                    risk
                        factors for recurrence of ischemic stroke.</article-title>
          <source>Stroke</source>
                    , <volume>25</volume> , <fpage>958</fpage> – <lpage>962</lpage> . <pub-id
                        pub-id-type="doi">https://doi.org/10.1161/01.STR.25.5.958</pub-id>
          <pub-id
                        pub-id-type="pmid">8165690</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Prencipe</surname>, <given-names>M.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Culasso</surname> , <given-names>F.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Rasura</surname> , <given-names>M.</given-names></string-name>, <string-name>
                            <surname>Anzini</surname> , <given-names>A.</given-names></string-name>, <string-name>
                            <surname>Beccia</surname> , <given-names>M.</given-names></string-name>, <string-name>
                            <surname>Cao</surname> , <given-names>M.</given-names></string-name>, <etal>.
                    . .</etal>
            <string-name>
                            <surname>Fieschi</surname> , <given-names>C.</given-names></string-name>
                    </person-group>
                    (
          <year>1998</year> ). <article-title>Long-term prognosis after a
                    minor
                        stroke: 10-year mortality and major stroke recurrence rates in a
                    hospital-based cohort.</article-title>
          <source>Stroke</source> , <volume>29</volume>
                    , <fpage>126</fpage> – <lpage>132</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1161/01.STR.29.1.126</pub-id>
          <pub-id pub-id-type="pmid">
                    9445340</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Rashid</surname>, <given-names>P.</given-names></string-name>, <string-name>
                            <surname>Leonardi-Bee</surname> , <given-names>J.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>Bath</surname> , <given-names>P.</given-names></string-name>
                    </person-group>
                    (
          <year>2003</year> ). <article-title>Blood pressure reduction and
                    secondary
                        prevention of stroke and other vascular events: A systematic
                        review.</article-title>
          <source>Stroke</source> , <volume>34</volume> , <fpage>
                    2741</fpage> – <lpage>2748</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1161/01.STR.0000092488.40085.15</pub-id>
          <pub-id
                        pub-id-type="pmid">14576382</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0010">
                <label>10</label>
                <?AuthorQuery id="Q5" queryText="eXtyles has not updated this reference because the authors returned by CrossRef are invalid: Girot, M., Mackowiak-Cordoliani, M.-A., Deplanque, D., H&#xFFFD;non, H., Lucas, C., &amp; Leys, D. (2005). Secondary prevention after ischemic stroke. Journal of Neurology, <italic>252</italic>, 14&#x2013;20. (Ref. 10 &quot;Girot, Mackowiak-Cordoliani, Deplanque, H&#x00E9;non, Lucas, Leys, 2005&quot;)"?>
        <mixed-citation publication-type="journal">
          <person-group person-group-type="author">
            <string-name>
              <surname>Girot</surname>,
          
              <given-names>M.</given-names></string-name>,
          
            <string-name>
              <surname>Mackowiak-Cordoliani</surname>
              ,
            
              <given-names>M. A.</given-names></string-name>,
          
            <string-name>
              <surname>Deplanque</surname>
              ,
            
              <given-names>D.</given-names></string-name>,
          
            <string-name>
              <surname>Hénon</surname>
              ,
            
              <given-names>H.</given-names></string-name>,
          
            <string-name>
              <surname>Lucas</surname>
              ,
            
              <given-names>C.</given-names></string-name>, &amp;
          
            <string-name>
              <surname>Leys</surname>
              ,
            
              <given-names>D.</given-names></string-name>
          </person-group>(
          <year>2005</year>
          ). 
          <article-title>Secondary prevention after ischemic
            stroke. Evolution over time in practice.</article-title>
          <source>Journal of Neurology</source>
          , 
          <volume>252</volume>
          ,
          
          <fpage>14</fpage>
          –
          <lpage>20</lpage>
          . 
          <pub-id pub-id-type="doi">https://doi.org/10.1007/s00415-005-0591-8</pub-id>
          <pub-id pub-id-type="pmid">15654550</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Johnson</surname>, <given-names>P.</given-names></string-name>, <string-name>
                            <surname>Rosewell</surname> , <given-names>M.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>James</surname> , <given-names>M.
                                A.</given-names></string-name>
                    </person-group>( <year>
                    2007</year> ). <article-title>How good is the management of vascular risk after
                    stroke,
                        transient ischaemic attack or carotid endarterectomy?</article-title>
          <source>Cerebrovascular
                    Diseases (Basel, Switzerland)</source> , <volume>23</volume> , <fpage>156</fpage>
                    – <lpage>161</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1159/000097053</pub-id>
          <pub-id pub-id-type="pmid">17124397</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Paul</surname>, <given-names>S.
                                L.</given-names></string-name>, &amp; <string-name>
                            <surname>Thrift</surname> , <given-names>A.
                                G.</given-names></string-name>
                    </person-group>( <year>
                    2006</year> ). <article-title>Control of hypertension 5 years after stroke in
                    the North
                        East Melbourne Stroke Incidence Study.</article-title>
          <source>Hypertension</source>
                    , <volume>48</volume> , <fpage>260</fpage> – <lpage>265</lpage> . <pub-id
                        pub-id-type="doi">https://doi.org/10.1161/01.HYP.0000230610.81947.04</pub-id>
          <pub-id
                        pub-id-type="pmid">16785330</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <?AuthorQuery id="Q6" queryText="Medline reports the journal title should be &quot;International journal of stroke : official journal of the International Stroke Society or Int J Stroke&quot;, not &quot;International Journal of Stroke&quot;. (Ref. 13 &quot;Hornnes, Larsen, Boysen, 2010&quot;)"?>
          <person-group person-group-type="author">
                        <string-name>
                            <surname>Hornnes</surname>, <given-names>N.</given-names></string-name>, <string-name>
                            <surname>Larsen</surname> , <given-names>K.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>Boysen</surname> , <given-names>G.</given-names></string-name>
                    </person-group>
                    (
          <year>2010</year> ). <article-title>Little change of modifiable risk
                    factors
                        1 year after stroke: A pilot study.</article-title>
          <source>International
                    Journal of Stroke</source> , <volume>5</volume> , <fpage>157</fpage> – <lpage>
                    162</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1111/j.1747-4949.2010.00424.x</pub-id>
          <pub-id
                        pub-id-type="pmid">20536611</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Adie</surname>, <given-names>K.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>James</surname> , <given-names>M.
                                A.</given-names></string-name>
                    </person-group>( <year>
                    2010</year> ). <article-title>Does telephone follow-up improve blood pressure
                    after minor
                        stroke or TIA?</article-title>
          <source>Age and Ageing</source> , <volume>39</volume>
                    , <fpage>598</fpage> – <lpage>603</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1093/ageing/afq085</pub-id>
          <pub-id pub-id-type="pmid">
                    20667838</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Chiu</surname>, <given-names>C.
                                C.</given-names></string-name>, <string-name>
                            <surname>Wu</surname> , <given-names>S. S.</given-names></string-name>, <string-name>
                            <surname>Lee</surname> , <given-names>P.
                                Y.</given-names></string-name>, <string-name>
                            <surname>Huang</surname> , <given-names>Y.
                                C.</given-names></string-name>, <string-name>
                            <surname>Tan</surname> , <given-names>T. Y.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>Chang</surname> , <given-names>K.
                                C.</given-names></string-name>
                    </person-group>( <year>
                    2008</year> ). <article-title>Control of modifiable risk factors in ischemic
                    stroke
                        outpatients by pharmacist intervention: An equal allocation stratified
                    randomized study.</article-title>
          <source>Journal of Clinical Pharmacy and
                    Therapeutics</source> , <volume>33</volume> , <fpage>529</fpage> – <lpage>535</lpage>
                    . <pub-id pub-id-type="doi">https://doi.org/10.1111/j.1365-2710.2008.00940.x</pub-id>
          <pub-id
                        pub-id-type="pmid">18834368</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Ellis</surname>, <given-names>G.</given-names></string-name>, <string-name>
                            <surname>Rodger</surname> , <given-names>J.</given-names></string-name>, <string-name>
                            <surname>McAlpine</surname> , <given-names>C.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>Langhorne</surname> , <given-names>P.</given-names></string-name>
                    </person-group>
                    (
          <year>2005</year> ). <article-title>The impact of stroke nurse
                    specialist
                        input on risk factor modification: A randomised controlled
                        trial.</article-title>
          <source>Age and Ageing</source> , <volume>34</volume>
                    , <fpage>389</fpage> – <lpage>392</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1093/ageing/afi075</pub-id>
          <pub-id pub-id-type="pmid">
                    15955759</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0017">
                <label>17</label>
                <?AuthorQuery id="Q7" queryText="Medline reports the journal title should be &quot;Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association or J Stroke Cerebrovasc Dis&quot;, not &quot;Journal of Stroke and Cerebrovascular Diseases&quot;. (Ref. 17 &quot;Hornnes, Larsen, Boysen, 2011&quot;)"?>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Hornnes</surname>, <given-names>N.</given-names></string-name>, <string-name>
                            <surname>Larsen</surname> , <given-names>K.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>Boysen</surname> , <given-names>G.</given-names></string-name>
                    </person-group>
                    (
          <year>2011</year> ). <article-title>Blood pressure 1 year after
                    stroke: The
                        need to optimize secondary prevention.</article-title>
          <source>Journal of
                    Stroke and Cerebrovascular Diseases</source> , <volume>20</volume> , <fpage>16</fpage>
                    – <lpage>23</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.10.002</pub-id>
          <pub-id
                        pub-id-type="pmid">21187254</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0018">
                <label>18</label>
                <?AuthorQuery id="Q8" queryText="CrossRef reports the first page should be &quot;NA&quot;, not &quot;579&quot;. (Ref. 18 &quot;Johnston, Sidney, Hills, Grosvenor, Klingman, Bernstein, Levin, 2010&quot;)"?>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Johnston</surname>, <given-names>S.
                                C.</given-names></string-name>, <string-name>
                            <surname>Sidney</surname> , <given-names>S.</given-names></string-name>, <string-name>
                            <surname>Hills</surname> , <given-names>N.
                                K.</given-names></string-name>, <string-name>
                            <surname>Grosvenor</surname> , <given-names>D.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Klingman</surname> , <given-names>J.
                                G.</given-names></string-name>, <string-name>
                            <surname>Bernstein</surname> , <given-names>A.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>Levin</surname> , <given-names>E.</given-names></string-name>
                    </person-group>
                    (
          <year>2010</year> ). <article-title>Standardized discharge orders
                    after
                        stroke: Results of the quality improvement in stroke prevention (QUISP)
                    cluster randomized trial.</article-title>
          <source>Annals of Neurology</source> , <volume>
                    67</volume> , <fpage>579</fpage> – <lpage>589</lpage> . <pub-id
                        pub-id-type="doi">https://doi.org/10.1002/ana.22019</pub-id>
          <pub-id
                        pub-id-type="pmid">20437555</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Joubert</surname>, <given-names>J.</given-names></string-name>, <string-name>
                            <surname>Reid</surname> , <given-names>C.</given-names></string-name>, <string-name>
                            <surname>Barton</surname> , <given-names>D.</given-names></string-name>, <string-name>
                            <surname>Cumming</surname> , <given-names>T.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>McLean</surname> , <given-names>A.</given-names></string-name>, <string-name>
                            <surname>Joubert</surname> , <given-names>L.</given-names></string-name>
                    , 
            <etal>. . .</etal>
            <string-name>
                            <surname>Davis</surname> , <given-names>S.</given-names></string-name>
                    </person-group>
                    (
          <year>2009</year> ). <article-title>Integrated care improves
                    risk-factor
                        modification after stroke: Initial results of the Integrated Care for the
                    Reduction of Secondary Stroke model.</article-title>
          <source>Journal of
                    Neurology, Neurosurgery, and Psychiatry</source> , <volume>80</volume> , <fpage>
                    279</fpage> – <lpage>284</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1136/jnnp.2008.148122</pub-id>
          <pub-id pub-id-type="pmid">
                    19010943</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0020">
                <label>20</label>
                <?AuthorQuery id="Q9" queryText="Medline reports multiple listings for this reference. Please check the reference for accuracy. (Ref. 20 &quot;Fahey, Schroeder, Ebrahim, 2006&quot;)"?>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Fahey</surname>, <given-names>T.</given-names></string-name>, <string-name>
                            <surname>Schroeder</surname> , <given-names>K.</given-names></string-name>,
                    &amp; <string-name>
                            <surname>Ebrahim</surname> , <given-names>S.</given-names></string-name>
                    </person-group>
                    (
          <year>2006</year> ). <article-title>Interventions used to improve
                    control of
                        blood pressure in patients with hypertension.</article-title>
          <source>Cochrane
                    Database of Systematic Reviews</source> , <elocation-id>CD005182</elocation-id>
                    .</mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Furie</surname>, <given-names>K.
                                L.</given-names></string-name>, <string-name>
                            <surname>Kasner</surname> , <given-names>S.
                                E.</given-names></string-name>, <string-name>
                            <surname>Adams</surname> , <given-names>R.
                                J.</given-names></string-name>, <string-name>
                            <surname>Albers</surname> , <given-names>G.
                                W.</given-names></string-name>, <string-name>
                            <surname>Bush</surname> , <given-names>R.
                                L.</given-names></string-name>, <string-name>
                            <surname>Fagan</surname> , <given-names>S. C.</given-names></string-name>
                    , 
            <etal>. . .</etal>
            <string-name>
                            <surname>Wentworth</surname> , <given-names>D.</given-names></string-name>,
                    &amp; the <collab>American
                            Heart Association Stroke Council, Council on Cardiovascular Nursing,
                    Council on Clinical Cardiology, and Interdisciplinary Council on Quality
                            of Care and Outcomes Research</collab></person-group>. ( <year>2011</year>
                    ). <article-title>Guidelines for the prevention of stroke
                        in patients with stroke or transient ischemic attack: A guideline for
                    healthcare professionals from the american heart association/american stroke
                    association.</article-title>
          <source>
                        <italic>Stroke</italic>
                    </source>, <volume>42</volume> , <fpage>
                    227</fpage> – <lpage>276</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1161/STR.0b013e3181f7d043</pub-id>
          <pub-id pub-id-type="pmid">
                    20966421</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0022">
                <label>22</label>
                <?AuthorQuery id="Q10" queryText="Medline reports the journal title should be &quot;The Cochrane database of systematic reviews or Cochrane Database Syst Rev&quot;, not &quot;Cochrane Database of Systematic Reviews&quot;. (Ref. 22 &quot;Bridgwood, Lager, Mistri, Khunti, Wilson, Modi, 2018&quot;)"?>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Bridgwood</surname>, <given-names>B.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Lager</surname> , <given-names>K.
                                E.</given-names></string-name>, <string-name>
                            <surname>Mistri</surname> , <given-names>A.
                                K.</given-names></string-name>, <string-name>
                            <surname>Khunti</surname> , <given-names>K.</given-names></string-name>, <string-name>
                            <surname>Wilson</surname> , <given-names>A.
                                D.</given-names></string-name>, &amp; <string-name>
                            <surname>Modi</surname> , <given-names>P.</given-names></string-name>
                    </person-group>
                    (
          <year>2018</year> ). <article-title>Interventions for improving
                    modifiable
                        risk factor control in the secondary prevention of stroke.</article-title>
          <source>Cochrane
                    Database of Systematic Reviews</source> , <volume>5</volume> , <elocation-id>
                    CD009103</elocation-id> . <pub-id pub-id-type="pmid">29734470</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0023">
                <label>23</label>
                <?AuthorQuery id="Q11" queryText="CrossRef reports the title is &quot;2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)&quot;. (Ref. 23 &quot;Mancia, Fagard, Narkiewicz, Red&#x00E1;n, Zanchetti, B&#x00F6;hm, Zannad, . . ., 2013&quot;)"?>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Mancia</surname>, <given-names>G.</given-names></string-name>, <string-name>
                            <surname>Fagard</surname> , <given-names>R.</given-names></string-name>, <string-name>
                            <surname>Narkiewicz</surname> , <given-names>K.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Redán</surname> , <given-names>J.</given-names></string-name>, <string-name>
                            <surname>Zanchetti</surname> , <given-names>A.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Böhm</surname> , <given-names>M.</given-names></string-name>, <etal>.
                    . .</etal>
            <string-name>
                            <surname>Zannad</surname> , <given-names>F.</given-names></string-name>,
                    &amp; the <collab>ESH/ESC
                            Task Force for the Management of Arterial
                            Hypertension</collab></person-group>. ( <year>2013</year> ). <article-title>
                    2013 Practice guidelines for the management of arterial hypertension of the <italic>
                    European</italic> Society of Hypertension (ESH) and the European Society of
                    Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial
                    Hypertension.</article-title>
          <source>Journal of Hypertension</source>, <volume>
                    31</volume> , <fpage>1925</fpage> – <lpage>1938</lpage> . <pub-id
                        pub-id-type="doi">https://doi.org/10.1097/HJH.0b013e328364ca4c</pub-id>
          <pub-id
                        pub-id-type="pmid">24107724</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>Boan</surname>, <given-names>A.
                                D.</given-names></string-name>, <string-name>
                            <surname>Lackland</surname> , <given-names>D.
                                T.</given-names></string-name>, &amp; <string-name>
                            <surname>Ovbiagele</surname> , <given-names>B.</given-names></string-name>
                    </person-group>
                    (
          <year>2014</year> ). <article-title>Lowering of blood pressure for
                    recurrent
                        stroke prevention.</article-title>
          <source>Stroke</source> , <volume>45</volume>
                    , <fpage>2506</fpage> – <lpage>2513</lpage> . <pub-id pub-id-type="doi">
                    https://doi.org/10.1161/STROKEAHA.114.003666</pub-id>
          <pub-id pub-id-type="pmid">
                    24984744</pub-id></mixed-citation>
            </ref>
            <ref id="BRB3-2019-12-0787-bib-0025">
                <label>25</label>
                <?AuthorQuery id="Q12" queryText="Medline reports the journal title should be &quot;CMAJ : Canadian Medical Association journal = journal de l&#x2019;Association medicale canadienne or CMAJ&quot;, not &quot;Canadian Medical Association Journal&quot;. (Ref. 25 &quot;McAlister, Majumdar, Padwal, Fradette, Thompson, Buck, Shuaib, . . ., 2014&quot;)"?>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <string-name>
                            <surname>McAlister</surname>, <given-names>F.
                                A.</given-names></string-name>, <string-name>
                            <surname>Majumdar</surname> , <given-names>S.
                                R.</given-names></string-name>, <string-name>
                            <surname>Padwal</surname> , <given-names>R.
                                S.</given-names></string-name>, <string-name>
                            <surname>Fradette</surname> , <given-names>M.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Thompson</surname> , <given-names>A.</given-names></string-name>
                    ,
          
            <string-name>
                            <surname>Buck</surname> , <given-names>B.</given-names></string-name>, <etal>.
                    . .</etal>
            <string-name>
                            <surname>Shuaib</surname> , <given-names>A.</given-names></string-name>
                    </person-group>
                    (
          <year>2014</year> ). <article-title>Case management for blood
                    pressure and
                        lipid level control after minor stroke: PREVENTION randomized controlled
                    trial.</article-title>
          <source>Canadian Medical Association Journal</source> , <volume>
                    186</volume> , <fpage>577</fpage> – <lpage>584</lpage> . <pub-id
                        pub-id-type="doi">https://doi.org/10.1503/cmaj.140053</pub-id>
          <pub-id
                        pub-id-type="pmid">24733770</pub-id></mixed-citation>
            </ref>
        </ref-list>
    </back>
</article>